Overview

ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial

Status:
Unknown status
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
ACTHAR gel has efficacy in the treatment of cutaneous sarcoidosis
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Albany Medical College
Treatments:
Adrenocorticotropic Hormone
beta-Endorphin
Melanocyte-Stimulating Hormones